SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): February 27, 1998
(February 27, 1998)
LASERSIGHT INCORPORATED
-----------------------
Exact name of registrant as specified in its charter
Delaware
State or other jurisdiction of incorporation
0-19671 65-0273162
------- ----------
Commission File Number I.R.S. Employer
Identification No.
12161 Lackland Road, St. Louis, Missouri 63146
----------------------------------------------
Address of Principal Executive Offices
Registrant's telephone number, including area code: (314) 469-3220
<PAGE>
Item 5. Other Events.
The press release issued by LaserSight Incorporated dated February 27, 1998 is
incorporated by reference herein.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) Exhibits
Exhibit 99. Press Release dated February 27, 1998
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
LaserSight Incorporated
Date: February 27, 1998 By: /s/ Michael R. Farris
-------------------------
Michael R. Farris
Chief Executive Officer
EXHIBIT 99
NASDAQ SYMBOL: LASE
LASERSIGHT INCORPORATED SHAREHOLDERS
PASS PROPOSALS AT SPECIAL MEETING FEB. 27, 1998
ST. LOUIS, MO (Feb. 27, 1998) - LaserSight Incorporated shareholders approved
all three proposals presented at the company's special meeting of shareholders
today. More than a quorum of overall votes were present.
Shareholders first approved the future issuance of shares of the
company's Common Stock resulting from conversions of LaserSight's Series B
Preferred Stock and the exercise of related stock purchase warrants. LaserSight
sold these securities in a private placement last August to fund its purchase
from International Business Machines Corporation (IBM) of a patent portfolio
related to a broad range of laser surgery technology. This proposal needed the
approval of a majority of shares voted on the proposal, and approximately 92
percent of the shares voted were in favor of its passage.
The shareholders also approved an increase in the number of authorized
shares of Common Stock from 20 million to 40 million. This proposal, which
needed the approval of a majority of shares outstanding, was approved by holders
of approximately 83 percent of the outstanding shares.
Finally, shareholders approved a proposal that would have allowed the
company to adjourn the special meeting to another date or place if there were
not enough votes today to approve the first two proposals. This proposal was
approved by 91 percent of the shares voted on it.
# # #
